Indications: Tirzepatide is a dual GIP and GLP-1 receptor agonist that may be prescribed by a licensed healthcare provider when clinically appropriate.
Mechanism of Action: It works by binding to and activating both endogenous GIP and GLP-1 receptors. This dual-activation pathway influences metabolic systems involved in blood glucose homeostasis and gastric emptying patterns.
Clinical Evaluation: Treatment is established following a formal clinical assessment and individualized patient evaluation. Periodic monitoring and laboratory tracking are utilized under medical supervision.
This is not an accurate representation of the medication packaging
Weight Loss
Tirzepatide (Comprehensive Labs Included) – 3-Month Supply
$1,535.00
A dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist available via provider prescription. It interacts directly with metabolic pathways and biological appetite signals.
| Dose | 2.5mg, 2.5mg, 5mg, 7.5mg, 5mg, 5mg, 7.5mg, 10mg, 7.5mg, 7.5mg, 10mg, 12.5mg, 10mg, 12.5mg, 12.5mg, 15mg, 15mg, 15mg |
|---|
Reviews
There are no reviews yet.